Cytometa: AI-Powered Cell Image Analysis System

Category: Cell Therapy and Regenerative Medicine

Exhibitor: PURPLE WIN INTERATIONAL LIMITED.

Booth No: L124

Characteristic

Cytometa, developed by Quastella, is an AI-driven image analysis system designed to support regenerative medicine and cell manufacturing. Leveraging deep learning, Cytometa detects subtle morphological differences in cell images and translates them into quantifiable quality metrics, enabling better monitoring of culture performance and process stability. The system supports various clinically relevant cell types, including mesenchymal stem cells (such as UC-MSCs and ADSCs) and induced pluripotent stem cells (iPSCs). It is ideal for applications such as condition screening, release decision support, and cell bank management. Cytometa has successfully completed multiple validation studies on cell morphology classification and is actively in discussion with academic and industry partners for future collaboration. It represents a forward-looking solution for intelligent, traceable, and automated cell manufacturing.